40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
View analysts' price targets and recommendations, and compare them with competitors.
$52.00
Lower upside than VET's upside of 42.44%.
Buy
Equal to VET's analyst recommendation of Buy.
Analyze analyst forecasts for the company and compare them with competitors.
10.41B
Better than VET's estimated revenue of 1.13B.
2.61B
Better than VET's estimated ebitda of 762.61M.
5.04
Better than VET's estimated eps of 1.60.
1.41B
Better than VET's estimated net income of 239.21M.
2.37B
Better than VET's estimated ebit of 222.78M.
444.58M
Worse than VET's estimated sg&a expense of 131.51M.
Analyze DCF forecasts for the company and compare them with competitors.
12.32B
Better than VET's revenue of 1.79B.
15.56%
Worse than VET's revenue growth rate of 17.50%.
2.46B
Better than VET's ebitda of 811.50M.
20.00%
Worse than VET's ebitda margin of 45.36%.
-37.17M
Worse than VET's ebit of 226.43M.
-0.30%
Worse than VET's ebit margin of 12.66%.
2.50B
Worse than VET's depreciation of 585.08M.
130.83M
Better than VET's total cash of 32.73M.
1.06%
Worse than VET's cash as percentage of revenue of 1.83%.
1.75B
Worse than VET's receivables of 224.09M.
14.23%
Worse than VET's receivables as percentage of revenue of 12.52%.
14.44M
Better than VET's inventories of 23.79M.
0.12%
Better than VET's inventories as percentage of revenue of 1.33%.
566.31M
Worse than VET's accounts payable of 255.03M.
4.60%
Better than VET's payables as percentage of revenue of 14.25%.
-3.09B
Better than VET's capital expenditure of -412.60M.
-25.11%
Better than VET's capex as percentage of revenue of -23.06%.
12.06%
Better than VET's weighted average cost of capital (wacc) of 13.24%.
16.87%
Worse than VET's cost of equity of 16.56%.
5.31%
Better than VET's cost of debt of 9.00%.
2.64
Worse than VET's beta of 2.58.
263.90M
Worse than VET's diluted shares outstanding of 163.72M.
6.68B
Worse than VET's total debt of 655.60M.
10.03B
Better than VET's total equity of 1.42B.
16.71B
Better than VET's total capital of 2.07B.
39.98%
Worse than VET's debt weighting of 31.64%.
60.02%
Worse than VET's equity weighting of 68.36%.
-34.00M
Worse than VET's ebiat of 152.42M.
-1.07B
Worse than VET's unlevered free cash flow of 291.18M.
0.50%
Worse than VET's long-term growth rate of 2.00%.
-12.22B
Worse than VET's terminal value of 5.64B.
-10.90B
Worse than VET's enterprise value of 4.55B.
6.68B
Worse than VET's net debt of 557.67M.
-17.58B
Worse than VET's equity value of 3.99B.
-66.63
Worse than VET's equity value per share of 24.38.
